Soleus Capital Master Fund, L.P. 13D and 13G filings for IRadimed Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:35 pm Sale | 2024-09-30 | 13G | IRadimed Corporation IRMD | Soleus Capital Master Fund, L.P. | 1,000 0.000% | -642,206 (-99.84%) | Filing |
| 2024-02-02 09:44 am Sale | 2023-12-31 | 13G | IRadimed Corporation IRMD | Soleus Capital Master Fund, L.P. | 643,206 5.100% | -101,798 (-13.66%) | Filing |
| 2023-02-14 08:16 am Purchase | 2022-12-31 | 13G | IRadimed Corporation IRMD | Soleus Capital Master Fund, L.P. | 745,004 5.900% | 98,593 (+15.25%) | Filing |
| 2022-09-01 09:00 am Purchase | 2022-08-29 | 13G | IRadimed Corporation IRMD | Soleus Capital Master Fund, L.P. | 646,411 5.100% | 646,411 (New Position) | Filing |